Study protocol for a multicenter randomised controlled trial on the (cost)effectiveness of biopsy combined with same-session MR-guided LITT versus biopsy alone in patients with primary irresectable glioblastoma (EMITT trial)

Study protocol for a multicenter randomised controlled trial on the (cost)effectiveness of biopsy combined with same-session MR-guided LITT versus biopsy alone in patients with primary irresectable glioblastoma (EMITT trial)

Abstract Background Glioblastoma (GBM) is the most common primary, malignant brain tumour with a 5-year survival of 5%. If possible, a glioblastoma is resected and further treated with chemoradiation therapy (CRT), but resection is not feasible in about 30% of cases. Current standard of care in thes...

Full description

Bibliographic Details
Main Authors: Céline L.G. Neutel, Ilaria Viozzi, Christiaan G. Overduin, Anne Rijpma, Janneke P.C. Grutters, Gerjon Hannink, Pieter van Eijsden, Pierre A. Robe, Maroeska M. Rovers, Mark ter Laan
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cancer
Subjects:
Glioblastoma
Laser ablation
Laser therapy
Ablation
Brain neoplasms
Magnetic resonance-guided laser-induced thermal therapy
Online Access:https://doi.org/10.1186/s12885-023-11282-7

Internet

https://doi.org/10.1186/s12885-023-11282-7

Similar Items